

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * cellular response to cadmium ion (GO:0071276) | 9.79240352 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 6.81184351 |
| 3 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.92834265 |
| 4 | angiotensin maturation (GO:0002003) | 5.27547505 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 5.23488420 |
| 6 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.98233944 |
| 7 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.98233944 |
| 8 | exogenous drug catabolic process (GO:0042738) | 4.94844244 |
| 9 | drug catabolic process (GO:0042737) | 4.83110487 |
| 10 | * response to zinc ion (GO:0010043) | 4.81077983 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.68615828 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59100281 |
| 13 | regulation of triglyceride catabolic process (GO:0010896) | 4.33879022 |
| 14 | ethanol oxidation (GO:0006069) | 4.32650578 |
| 15 | phospholipid efflux (GO:0033700) | 4.32534255 |
| 16 | drug metabolic process (GO:0017144) | 4.32454216 |
| 17 | negative regulation of cholesterol transport (GO:0032375) | 4.21788130 |
| 18 | negative regulation of sterol transport (GO:0032372) | 4.21788130 |
| 19 | urea metabolic process (GO:0019627) | 4.19969811 |
| 20 | eosinophil chemotaxis (GO:0048245) | 4.14632308 |
| 21 | regulation of macrophage chemotaxis (GO:0010758) | 4.13322365 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.06862857 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 4.06862857 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 4.04582249 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.03159025 |
| 26 | * response to cadmium ion (GO:0046686) | 4.01643352 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.00177373 |
| 28 | peptide catabolic process (GO:0043171) | 3.99478873 |
| 29 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.95415676 |
| 30 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.94862593 |
| 31 | fructose metabolic process (GO:0006000) | 3.93695273 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.93216332 |
| 33 | L-phenylalanine catabolic process (GO:0006559) | 3.93216332 |
| 34 | urea cycle (GO:0000050) | 3.89805992 |
| 35 | acute-phase response (GO:0006953) | 3.83063641 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66933040 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.66933040 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.66933040 |
| 39 | glycosphingolipid catabolic process (GO:0046479) | 3.65893202 |
| 40 | eosinophil migration (GO:0072677) | 3.65196712 |
| 41 | glucuronate metabolic process (GO:0019585) | 3.61812110 |
| 42 | uronic acid metabolic process (GO:0006063) | 3.61812110 |
| 43 | cellular glucuronidation (GO:0052695) | 3.57287114 |
| 44 | cholesterol efflux (GO:0033344) | 3.55553160 |
| 45 | glycolipid catabolic process (GO:0019377) | 3.55472455 |
| 46 | bile acid and bile salt transport (GO:0015721) | 3.53400776 |
| 47 | NADH metabolic process (GO:0006734) | 3.52372805 |
| 48 | intestinal absorption (GO:0050892) | 3.51936090 |
| 49 | vitamin biosynthetic process (GO:0009110) | 3.40063914 |
| 50 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36423006 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.34770172 |
| 52 | aromatic amino acid family catabolic process (GO:0009074) | 3.34674478 |
| 53 | ethanol metabolic process (GO:0006067) | 3.32724823 |
| 54 | adhesion of symbiont to host cell (GO:0044650) | 3.26368756 |
| 55 | virion attachment to host cell (GO:0019062) | 3.26368756 |
| 56 | bile acid metabolic process (GO:0008206) | 3.26221381 |
| 57 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.25757814 |
| 58 | complement activation (GO:0006956) | 3.22002510 |
| 59 | regulation of vitamin metabolic process (GO:0030656) | 3.21172240 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20745110 |
| 61 | regulation of protein activation cascade (GO:2000257) | 3.19000993 |
| 62 | complement activation, classical pathway (GO:0006958) | 3.15158442 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 3.10829412 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.08124588 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 3.06672184 |
| 66 | regulation of complement activation (GO:0030449) | 3.06324915 |
| 67 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05408210 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.03003897 |
| 69 | reverse cholesterol transport (GO:0043691) | 3.01255638 |
| 70 | plasma lipoprotein particle organization (GO:0071827) | 3.00915216 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 2.98185228 |
| 72 | protein activation cascade (GO:0072376) | 2.98033981 |
| 73 | lipoprotein metabolic process (GO:0042157) | 2.95208072 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 2.94192455 |
| 75 | ceramide catabolic process (GO:0046514) | 2.92857258 |
| 76 | L-ascorbic acid metabolic process (GO:0019852) | 2.92656825 |
| 77 | membrane lipid catabolic process (GO:0046466) | 2.91406229 |
| 78 | fibrinolysis (GO:0042730) | 2.90556549 |
| 79 | triglyceride homeostasis (GO:0070328) | 2.88019212 |
| 80 | acylglycerol homeostasis (GO:0055090) | 2.88019212 |
| 81 | protein-lipid complex subunit organization (GO:0071825) | 2.87750656 |
| 82 | apoptotic cell clearance (GO:0043277) | 2.86793220 |
| 83 | regulation of apoptotic cell clearance (GO:2000425) | 2.86238838 |
| 84 | protein-lipid complex assembly (GO:0065005) | 2.85592809 |
| 85 | regulation of guanylate cyclase activity (GO:0031282) | 2.84284246 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 2.82637275 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 2.82637275 |
| 88 | tryptophan catabolic process (GO:0006569) | 2.82637275 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82374017 |
| 90 | hormone catabolic process (GO:0042447) | 2.82013256 |
| 91 | adhesion of symbiont to host (GO:0044406) | 2.80869044 |
| 92 | acute inflammatory response (GO:0002526) | 2.79561890 |
| 93 | sphingolipid catabolic process (GO:0030149) | 2.78989214 |
| 94 | cellular response to ethanol (GO:0071361) | 2.77803433 |
| 95 | negative regulation of hemostasis (GO:1900047) | 2.75741742 |
| 96 | negative regulation of blood coagulation (GO:0030195) | 2.75741742 |
| 97 | bile acid biosynthetic process (GO:0006699) | 2.73711384 |
| 98 | alkaloid metabolic process (GO:0009820) | 2.72426384 |
| 99 | negative regulation of coagulation (GO:0050819) | 2.72422965 |
| 100 | * cellular response to zinc ion (GO:0071294) | 12.6502014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.19386458 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.79218210 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.72719936 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56873965 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.44821036 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.35593990 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00897583 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.99686797 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91388592 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.83715666 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.73130673 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.62370830 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.32864119 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17561878 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17045073 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13665518 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09478914 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.07354671 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98416876 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92553188 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.89198844 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88757659 |
| 23 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.88374574 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85683108 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81944504 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74204004 |
| 27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62944001 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61051173 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59913014 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59563153 |
| 31 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53213721 |
| 32 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.51745785 |
| 33 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.43589982 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.39225184 |
| 35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.38814977 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38063946 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35753156 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33950850 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33612756 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33390822 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.32817323 |
| 42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32811086 |
| 43 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31837012 |
| 44 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31122345 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30443689 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.29996834 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28370421 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.27860660 |
| 49 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.23942683 |
| 50 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22104751 |
| 51 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20622698 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18664619 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16954301 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16346671 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15844290 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15572276 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13572579 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12133105 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10158713 |
| 60 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09935573 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09401070 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08892178 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08483981 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08199731 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07938519 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07059366 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06433798 |
| 68 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06399455 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05546069 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05084991 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04793307 |
| 72 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04020216 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03102794 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00858154 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00377140 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00173450 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98003060 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97659654 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96985595 |
| 80 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96815324 |
| 81 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96497439 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.95249761 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94784374 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94370228 |
| 85 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93334383 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92926382 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92795860 |
| 88 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.92716675 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92440836 |
| 90 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91834310 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91371588 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91005129 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90476768 |
| 94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89451484 |
| 95 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89421568 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88631057 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88236324 |
| 98 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.87920327 |
| 99 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87766614 |
| 100 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.86438818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.33645939 |
| 2 | MP0005360_urolithiasis | 5.03376542 |
| 3 | MP0009840_abnormal_foam_cell | 4.88656474 |
| 4 | MP0005365_abnormal_bile_salt | 4.04582130 |
| 5 | MP0003195_calcinosis | 3.52460175 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.48071318 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.02650611 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.01369023 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.92098072 |
| 10 | MP0009785_altered_susceptibility_to | 2.85653327 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.77940154 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.54912018 |
| 13 | MP0003436_decreased_susceptibility_to | 2.46018521 |
| 14 | MP0009764_decreased_sensitivity_to | 2.20799709 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.15991146 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.12049132 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.05138160 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.02010159 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.00148828 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.89956321 |
| 21 | MP0005332_abnormal_amino_acid | 1.88778768 |
| 22 | MP0003075_altered_response_to | 1.88349358 |
| 23 | MP0009278_abnormal_bone_marrow | 1.85204885 |
| 24 | MP0000343_altered_response_to | 1.82305511 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.79854401 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.74992841 |
| 27 | MP0000604_amyloidosis | 1.73409576 |
| 28 | MP0002419_abnormal_innate_immunity | 1.71385352 |
| 29 | MP0005166_decreased_susceptibility_to | 1.67592273 |
| 30 | MP0005025_abnormal_response_to | 1.56913962 |
| 31 | MP0002254_reproductive_system_inflammat | 1.53179199 |
| 32 | MP0006082_CNS_inflammation | 1.51375104 |
| 33 | MP0001853_heart_inflammation | 1.49829730 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.43421674 |
| 35 | MP0008469_abnormal_protein_level | 1.42017378 |
| 36 | MP0001764_abnormal_homeostasis | 1.40713693 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.38651588 |
| 38 | MP0003303_peritoneal_inflammation | 1.37438078 |
| 39 | MP0003868_abnormal_feces_composition | 1.35609942 |
| 40 | MP0008260_abnormal_autophagy | 1.33825327 |
| 41 | MP0001790_abnormal_immune_system | 1.31686064 |
| 42 | MP0005387_immune_system_phenotype | 1.31686064 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.30612228 |
| 44 | MP0000609_abnormal_liver_physiology | 1.29971332 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.25418160 |
| 46 | MP0002118_abnormal_lipid_homeostasis | 1.23074307 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.21715659 |
| 48 | MP0003252_abnormal_bile_duct | 1.20262358 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.19880977 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.16655237 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.16050876 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.12944074 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.12944074 |
| 54 | MP0009765_abnormal_xenobiotic_induced | 1.12757398 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.12497411 |
| 56 | MP0003690_abnormal_glial_cell | 1.08394369 |
| 57 | MP0005670_abnormal_white_adipose | 1.07746677 |
| 58 | MP0004510_myositis | 1.07382991 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.06627534 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.06276986 |
| 61 | MP0009763_increased_sensitivity_to | 1.04587335 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03565022 |
| 63 | MP0005023_abnormal_wound_healing | 1.01822044 |
| 64 | MP0003186_abnormal_redox_activity | 1.01226652 |
| 65 | MP0003329_amyloid_beta_deposits | 0.96092901 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 0.94605252 |
| 67 | MP0003448_altered_tumor_morphology | 0.94427806 |
| 68 | MP0005671_abnormal_response_to | 0.93085508 |
| 69 | MP0005451_abnormal_body_composition | 0.92855680 |
| 70 | MP0002452_abnormal_antigen_presenting | 0.91405901 |
| 71 | MP0001849_ear_inflammation | 0.88058785 |
| 72 | MP0000858_altered_metastatic_potential | 0.86977966 |
| 73 | MP0000678_abnormal_parathyroid_gland | 0.85720133 |
| 74 | MP0001835_abnormal_antigen_presentation | 0.85308150 |
| 75 | MP0008874_decreased_physiological_sensi | 0.85053484 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.84334482 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.84253297 |
| 78 | MP0002723_abnormal_immune_serum | 0.81750403 |
| 79 | MP0000249_abnormal_blood_vessel | 0.80038120 |
| 80 | MP0000685_abnormal_immune_system | 0.76354064 |
| 81 | MP0000920_abnormal_myelination | 0.76104890 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.75483230 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.75315771 |
| 84 | MP0003879_abnormal_hair_cell | 0.74518597 |
| 85 | MP0001663_abnormal_digestive_system | 0.72603901 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.72446994 |
| 87 | MP0009642_abnormal_blood_homeostasis | 0.72177234 |
| 88 | MP0005310_abnormal_salivary_gland | 0.71963714 |
| 89 | MP0003828_pulmonary_edema | 0.71959891 |
| 90 | MP0001800_abnormal_humoral_immune | 0.71935859 |
| 91 | MP0003724_increased_susceptibility_to | 0.70109290 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.68664676 |
| 93 | MP0003878_abnormal_ear_physiology | 0.68664676 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.68468518 |
| 95 | MP0001756_abnormal_urination | 0.66566622 |
| 96 | MP0004947_skin_inflammation | 0.66545048 |
| 97 | MP0001819_abnormal_immune_cell | 0.66539158 |
| 98 | MP0004043_abnormal_pH_regulation | 0.66167131 |
| 99 | MP0004883_abnormal_blood_vessel | 0.64974693 |
| 100 | MP0000490_abnormal_crypts_of | 0.64816448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.65197641 |
| 2 | Complement deficiency (HP:0004431) | 6.17708877 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.72099686 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.41352397 |
| 5 | Abnormality of complement system (HP:0005339) | 5.08175720 |
| 6 | Malnutrition (HP:0004395) | 4.96231841 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.75227810 |
| 8 | Xanthomatosis (HP:0000991) | 4.75002423 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.66641721 |
| 10 | Glomerulonephritis (HP:0000099) | 4.59419763 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.14832399 |
| 12 | Hydroxyprolinuria (HP:0003080) | 3.72998404 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 3.72998404 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.62782220 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60390953 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55421522 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55421522 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55421522 |
| 19 | Deep venous thrombosis (HP:0002625) | 3.50402977 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.47113967 |
| 21 | Fat malabsorption (HP:0002630) | 3.38329638 |
| 22 | Metaphyseal irregularity (HP:0003025) | 3.15871979 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.12802129 |
| 24 | Steatorrhea (HP:0002570) | 3.10621195 |
| 25 | Nephritis (HP:0000123) | 3.05259357 |
| 26 | Nausea (HP:0002018) | 3.04276763 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.00521503 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.94502691 |
| 29 | Widely patent fontanelles and sutures (HP:0004492) | 2.88644567 |
| 30 | Hypophosphatemia (HP:0002148) | 2.85945810 |
| 31 | Increased serum ferritin (HP:0003281) | 2.84515467 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.76263233 |
| 33 | Joint hemorrhage (HP:0005261) | 2.66310488 |
| 34 | Abnormal hemoglobin (HP:0011902) | 2.63288533 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 2.63236667 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.62658691 |
| 37 | Hyperlipoproteinemia (HP:0010980) | 2.62017123 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.56343263 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.53392352 |
| 40 | Abnormality of iron homeostasis (HP:0011031) | 2.50550295 |
| 41 | Protuberant abdomen (HP:0001538) | 2.47944185 |
| 42 | Intrahepatic cholestasis (HP:0001406) | 2.44734208 |
| 43 | Thin bony cortex (HP:0002753) | 2.41166528 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40132425 |
| 45 | Symptomatic seizures (HP:0011145) | 2.39654664 |
| 46 | Hyperammonemia (HP:0001987) | 2.38997828 |
| 47 | Retinal atrophy (HP:0001105) | 2.36972722 |
| 48 | Delayed epiphyseal ossification (HP:0002663) | 2.36945277 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35701446 |
| 50 | Purpura (HP:0000979) | 2.34523071 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.31913876 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.31913876 |
| 53 | Loss of speech (HP:0002371) | 2.31702175 |
| 54 | Pancreatitis (HP:0001733) | 2.31429193 |
| 55 | Amyloidosis (HP:0011034) | 2.30828047 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.30468644 |
| 57 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.30167607 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25419175 |
| 59 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.25259018 |
| 60 | Elevated alkaline phosphatase (HP:0003155) | 2.25197419 |
| 61 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.25036422 |
| 62 | Hyperglycinuria (HP:0003108) | 2.24343285 |
| 63 | Metabolic alkalosis (HP:0200114) | 2.23193220 |
| 64 | Alkalosis (HP:0001948) | 2.21489076 |
| 65 | Bone pain (HP:0002653) | 2.20019411 |
| 66 | Abnormality of vitamin metabolism (HP:0100508) | 2.19775463 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.18508832 |
| 68 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18228777 |
| 69 | Visceral angiomatosis (HP:0100761) | 2.16965236 |
| 70 | Confusion (HP:0001289) | 2.16807445 |
| 71 | Mutism (HP:0002300) | 2.16045341 |
| 72 | Petechiae (HP:0000967) | 2.14902102 |
| 73 | Myocardial infarction (HP:0001658) | 2.14522941 |
| 74 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11755703 |
| 75 | Gingivitis (HP:0000230) | 2.10741030 |
| 76 | Neurofibrillary tangles (HP:0002185) | 2.09305529 |
| 77 | Abdominal distention (HP:0003270) | 2.08244765 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.07778684 |
| 79 | Irritability (HP:0000737) | 2.07609577 |
| 80 | Pathologic fracture (HP:0002756) | 2.06693549 |
| 81 | Rickets (HP:0002748) | 2.06489734 |
| 82 | Premature loss of primary teeth (HP:0006323) | 2.05860605 |
| 83 | Ileus (HP:0002595) | 2.04977690 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.04475313 |
| 85 | Glycosuria (HP:0003076) | 2.04475313 |
| 86 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04391562 |
| 87 | Nephrolithiasis (HP:0000787) | 2.03044814 |
| 88 | Hematochezia (HP:0002573) | 2.02644698 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01411677 |
| 90 | Bone cyst (HP:0012062) | 2.00628396 |
| 91 | Axonal loss (HP:0003447) | 1.98828545 |
| 92 | Hemangiomatosis (HP:0007461) | 1.94749062 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93334193 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93334193 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93334193 |
| 96 | Chronic diarrhea (HP:0002028) | 1.91805448 |
| 97 | Abnormality of the costochondral junction (HP:0000919) | 1.90507664 |
| 98 | Hyperactive renin-angiotensin system (HP:0000841) | 1.89916231 |
| 99 | Epidermoid cyst (HP:0200040) | 1.88975326 |
| 100 | Hypoalphalipoproteinemia (HP:0003233) | 1.88899110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.16169115 |
| 2 | ERN1 | 4.29361839 |
| 3 | NME2 | 3.76340142 |
| 4 | TGFBR2 | 3.00397375 |
| 5 | BLK | 2.86328938 |
| 6 | RIPK4 | 2.72418635 |
| 7 | DDR2 | 2.66874448 |
| 8 | MATK | 2.60361740 |
| 9 | PRKG2 | 2.48480270 |
| 10 | TYK2 | 2.35498850 |
| 11 | IRAK3 | 2.16597430 |
| 12 | TESK1 | 2.11197282 |
| 13 | ABL2 | 1.92857069 |
| 14 | RIPK1 | 1.90518967 |
| 15 | CSK | 1.84585789 |
| 16 | FGR | 1.81967479 |
| 17 | MAP3K11 | 1.79754613 |
| 18 | MAP3K3 | 1.79655718 |
| 19 | TESK2 | 1.64866597 |
| 20 | MAP3K13 | 1.58014324 |
| 21 | PDK2 | 1.54005841 |
| 22 | CSF1R | 1.49746254 |
| 23 | OXSR1 | 1.44701723 |
| 24 | MAP3K12 | 1.44124111 |
| 25 | LMTK2 | 1.33048484 |
| 26 | CDC42BPA | 1.30156833 |
| 27 | MAP3K1 | 1.29334774 |
| 28 | TAOK1 | 1.28415196 |
| 29 | LIMK1 | 1.27856531 |
| 30 | MAP3K14 | 1.22198313 |
| 31 | TAOK2 | 1.22087732 |
| 32 | EPHB2 | 1.21617748 |
| 33 | MAP2K6 | 1.20769017 |
| 34 | GRK7 | 1.19938223 |
| 35 | TBK1 | 1.17530924 |
| 36 | PRPF4B | 1.12349948 |
| 37 | ARAF | 1.11947604 |
| 38 | FGFR4 | 1.10091652 |
| 39 | PBK | 1.08836738 |
| 40 | MAP4K1 | 1.07991195 |
| 41 | TGFBR1 | 1.07391417 |
| 42 | DAPK2 | 1.02916274 |
| 43 | PAK4 | 1.02638221 |
| 44 | PDPK1 | 0.94942397 |
| 45 | LYN | 0.94492202 |
| 46 | MST1R | 0.92614937 |
| 47 | KSR2 | 0.92338098 |
| 48 | MAP3K2 | 0.87843787 |
| 49 | IKBKB | 0.84850946 |
| 50 | CAMKK2 | 0.84576917 |
| 51 | MST4 | 0.84496646 |
| 52 | PRKAA2 | 0.84389802 |
| 53 | IKBKE | 0.80452992 |
| 54 | ADRBK2 | 0.79034847 |
| 55 | KDR | 0.73383279 |
| 56 | IRAK4 | 0.72907370 |
| 57 | BCKDK | 0.70553472 |
| 58 | PRKACG | 0.70235329 |
| 59 | TYRO3 | 0.70050878 |
| 60 | ZAP70 | 0.69575680 |
| 61 | EPHA2 | 0.66602620 |
| 62 | CAMK1D | 0.66212938 |
| 63 | BMX | 0.65242015 |
| 64 | RPS6KC1 | 0.64728749 |
| 65 | RPS6KL1 | 0.64728749 |
| 66 | MAP2K3 | 0.64268513 |
| 67 | TNIK | 0.61449544 |
| 68 | RPS6KA2 | 0.60859178 |
| 69 | PTK6 | 0.59894994 |
| 70 | JAK3 | 0.56033322 |
| 71 | PDK1 | 0.51742129 |
| 72 | MYLK | 0.51157911 |
| 73 | RPS6KA6 | 0.50281579 |
| 74 | MAP3K8 | 0.49741467 |
| 75 | PRKCA | 0.49266498 |
| 76 | PRKCD | 0.47835954 |
| 77 | JAK1 | 0.45879410 |
| 78 | JAK2 | 0.45740837 |
| 79 | SMG1 | 0.45458814 |
| 80 | SRC | 0.43377361 |
| 81 | STK16 | 0.42769447 |
| 82 | PDGFRA | 0.42466153 |
| 83 | GRK6 | 0.41826362 |
| 84 | SYK | 0.38302972 |
| 85 | PRKCZ | 0.37390702 |
| 86 | IGF1R | 0.37111385 |
| 87 | EPHA3 | 0.37057330 |
| 88 | EEF2K | 0.36933207 |
| 89 | MAPK12 | 0.36429907 |
| 90 | CAMK2G | 0.35587691 |
| 91 | MAP2K4 | 0.35091576 |
| 92 | LCK | 0.33623110 |
| 93 | STK24 | 0.33352990 |
| 94 | PRKCG | 0.33179593 |
| 95 | MAPKAPK3 | 0.31568570 |
| 96 | BRAF | 0.31511726 |
| 97 | MAP2K2 | 0.31149106 |
| 98 | ALK | 0.29899158 |
| 99 | KIT | 0.29564417 |
| 100 | FYN | 0.29534395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 4.00272847 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.19522801 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.95789619 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57248728 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.50333209 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.44750641 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.44203183 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.42814672 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.26905627 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.26738384 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26328115 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.23935847 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17743365 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14806075 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.14161090 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03748277 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.00055601 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97371704 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93554133 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90454692 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80811940 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.78399939 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75039424 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73353773 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69896935 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67139829 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65443970 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.54551617 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53565195 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51877589 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48193929 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43899350 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38123268 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36711040 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35718199 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.35260982 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.33849991 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.31328925 |
| 39 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31111990 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25147641 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17434166 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.13125155 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12485770 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11906092 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.09665051 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.07552835 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00075585 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96672550 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82224012 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79751706 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78526312 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75980997 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74552543 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73784609 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.70967295 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70735714 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70215982 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69905239 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69221372 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.68809619 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68198650 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.66394587 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64680631 |
| 64 | Tuberculosis_Homo sapiens_hsa05152 | 0.63840458 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63618555 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.62668582 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60869269 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59647260 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59167837 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59107268 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.58144299 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57387954 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.55047078 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54654598 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51724695 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51366375 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49726518 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48890392 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.44008478 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43405180 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42686872 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41561707 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41017679 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40062582 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38752387 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37245140 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35021584 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34691281 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.34644034 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34109638 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34045744 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33227009 |
| 93 | Bladder cancer_Homo sapiens_hsa05219 | 0.32467873 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.32278078 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31871351 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31679861 |
| 97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31021074 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30350129 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27186913 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23137260 |

